The survey findings, published in the Journal of Managed Care & Specialty Pharmacy, showed 62% of respondents predict that the number of active drug shortages will rise by more than 25% within five years, potentially worsening patient access to critical medications.
In addition, 92% of respondents reported they anticipate AI will be more integrated into more than half of prior authorization reviews.
Another pressing concern for participants was the rise in drug costs, with 54% expecting at least half of U.S. states to establish drug-affordability boards. Additionally, 97% foresee a 25% surge in GLP-1 therapies.
The foundation is the philanthropic arm of the AMCP.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
